Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 35.05
+0.05 (0.14%)
May 8, 2026, 3:00 PM CST
123.39% (1Y)
| Market Cap | 14.22B +161.4% |
| Revenue (ttm) | 774.47M +27.9% |
| Net Income | 56.52M +42.4% |
| EPS | 0.14 +42.6% |
| Shares Out | 405.71M |
| PE Ratio | 251.22 |
| Forward PE | 194.72 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,771,186 |
| Average Volume | 9,488,041 |
| Open | 35.08 |
| Previous Close | 35.00 |
| Day's Range | 34.50 - 35.93 |
| 52-Week Range | 14.93 - 35.93 |
| Beta | 0.39 |
| RSI | 69.39 |
| Earnings Date | Apr 30, 2026 |